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ABSTRACT
Haematologica 1998; 83:87-89 case of the month
mablastic lymphoma; so far, only one other case
with these features has been described as arising in
the stomach.6
Case report
A 53 year-old woman complaining of epigastric
distension was admitted to the Emergency Room of
the Ospedale Maggiore of Milan. The patient had
suffered for ten days from postprandial fullness, left
upper quadrant pain and hypochondria with deep
asthenia; moreover, she reported a slight fever in
the evening, tachycardia and dyspnea. During phys-
ical examination, cutaneous pallor was evident and
a large abdominal mass in epigastrium was palpa-
ble. Blood count showed severe microcytic anemia;
serologic test was negative for HIV infection. The
electrophoretic pattern of serum proteins was nor-
mal. A gastroscopy showed a large gastric polypoid
mass from which biopsies were taken. The mor-
phology of the gastric biopsy was in keeping with a
high-grade gastric lymphoma. A subtotal gastrecto-
my and a gastro-jejunal termino-lateral anastomo-
sis were done; 30 centimeters of transverse colon,
firmly adherent to the stomach, were also removed.
The gastric specimen showed an ulcerating bulky-
polypoid large neoplasm measuring 25 centimeters
in diameter. Histologically, the tumor was com-
posed of large cells with peripherally located nuclei,
one or more basophilic central nucleoli, and abun-
dant strongly basophilic cytoplasm, often contain-
ing pale vacuoles, intermingled with plasmablasts
(Figure 1A and 1B). Mitotic rate was high (30310
HPF) and diffuse areas of necrosis were detectable.
The normal frame of the gastric mucosa was
effaced, without formation of lympho-epithelial
lesions. The tumor infiltrated the full thickness of
the gastric wall, the adipose tissue of the stomach
and transverse colon; the perigastric lymph nodes
were free of lymphoma (stage III according to
Shimodaira et al.7). Despite extensive sampling, a
low-grade component was undetectable. The unin-
volved mucosa showed mild chronic non-follicular
gastritis. Helicobacter pylori micro-organisms were
not detected, neither by light microscopy with
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We report the case of a 53 year-old woman with a
gastric tumor showing morphological, phenotypi-
cal and molecular features of a plasmablastic lym-
phoma, a recently recognized subtype of diffuse
large B-cell lymphoma. The tumor was composed
of plasmablast-like cells, lacked CD45 and B-cell
associated antigens, expressed the plasma cell-
associated antigen CD38, and showed clonally
rearranged IgH genes in the absence of bcl-2 and
bcl-6 genes rearrangement.
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The stomach is the most common site of originof extranodal lymphomas.1 Most of the gas-tric lymphomas develop from the acquired
mucosa-associated lymphoid tissue (MALT),2 and
are therefore termed MALT lymphomas (extranodal
marginal zone B-cell lymphoma according to the
REAL classification).3 They are divided into low-
grade and high-grade tumors with a low-grade
component. Nevertheless, since a minority of high-
grade tumors does not show any low-grade compo-
nent, the existence of truly primitive gastric diffuse
large cell B-lymphomas (DLBCL) is accepted. In
1992 Stein and Dallenbach coined the term plas-
mablastic lymphoma for rare DLBCL (1.5% of all
nodal non-Hodgkin lymphomas) showing the mor-
phological features of immunoblastic lymphoma
with plasmacytic differentiation and phenotypical
properties of plasmacytoma (CD45 negative, B-cell
antigens negative, immunoglobulin positive with
light chain restriction, and up to 20% of cytoker-
atin-expressing cells4). More recently, Delecluse et
al. have reported that lymphomas with similar mor-
phological and phenotypical features may develop
in the oral cavity of HIV-infected patients.5 We
describe the case of a non-immunocompromized
patient with a gastric tumor showing morphologi-
cal, phenotypical and molecular features of plas-
Giemsa stain, nor with antibodies recognizing
Helicobacter-associated antigens. The phenotype
was obtained by means of immunohistochemistry
(ABC method) and flow cytometry: tumoral cells
did not express leukocyte common (LCA), T-cell
(CD3, CD5, CD43 and CD45RO) and CD10 anti-
gens. Moreover, they almost completely lacked the
B-cell associated antigens CD19, CD20 (Figure 1C)
and CD79a, while strongly expressed CD38.
Likewise, the neoplastic cells proved to be unreac-
tive to the anti-CD56 antibody. On the other hand,
diffuse cytoplasmic IgM and J-chain expression,
associated with light chain restriction was detected.
A few cells also showed immunoreactivity for anti-
bodies raised against EMA (Figure 1D) and cytoker-
atin. Moreover, most of them strongly expressed
bcl-2 protein, whereas p53 and bcl-6 antigens were
lacking. The proliferative rate, as detected by MIB-1
antibody, was about 50%. Molecular analysis was
performed as previously described.8 Southern blot
analysis using the JH probe to hybridize EcoRI- and
HindIII-digested DNA showed a monoclonal pat-
tern of IgH gene rearrangement. Absence of
rearrangement of the bcl-1, bcl-2 and bcl-6 loci was
observed in Southern blot analysis. PCR/SSCP
analysis of the exons 5 through 9 of the p53 tumor
suppressor gene did not detect changes in the nor-
mal migrating pattern. Since no lymphoadenopathy
was detectable by means of CT scans and ultra-
sonography of the abdomen, and the bone marrow
and liver biopsies were free of lymphoma at histo-
logical evaluation, the patient was staged as IE. She
was treated with ProMACE-cytaBOM regimen for
six courses and is alive and well and free of disease
19 months after diagnosis. 
Discussion
Plasmablastic lymphomas are diffuse large-cell
tumours composed by plasmablast-like cells which
lack CD20 and CD45, and diffusely express plasma
cell-associated antigens. Stein and Dallenbach
found that this type of tumor accounts for about
1.5% of nodal non-Hodgkin lymphomas.4 More
recently, Delecluse et al. have reported a series of 16
plasmablastic lymphomas primitively arising in the
oral mucosa of HIV-infected patients.5
We here describe a case of a tumor with morpho-
logical and phenotypical properties of a plas-
mablastic lymphoma, arising in the stomach of a
non-immunocompromized patient. It strikingly dif-
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Figure 1.
A: Diffuse proliferation of large cells
effacing the normal frame of the gas-
tric wall (hematoxylin-eosin, 332). 
B: The tumor is composed of large
cells with peripherally located nuclei,
one or more basophilic central nucleoli,
and abundant strongly basophilic cyto-
plasm containing pale vacuoles, inter-
mingled with plasmablasts (arrow-
heads) and multinucleated giant cells
(Giemsa; 3200).
C: A single cell immunoreactive to anti-
CD20 antibody: the overwhelming
majority of the tumor is unreactive
(ABC method, haematoxylin counter-
stain, 380).
D: A few tumor cells are stained with
the anti-EMA antibody (ABC method,
hematoxylin counterstain, 380).
89
ferentiates from high-grade MALT lymphomas for
the absence of a low grade component as well as of
any sign of Helicobacter pylori infection, the diffuse
plasmablastic differentiation, and the lack of CD45
and CD20 in the presence of strong CD38 expres-
sion. Likewise, De Mascarel et al. reported the case
of a patient with a gastric large cell lymphoma
composed by plasmablasts, which expressed cytok-
eratin and monotypic IgA but no leukocyte com-
mon antigen.6 These data suggest that plasmablas-
tic lymphoma may develop in extranodal sites dif-
ferent from oral mucosa, and it is not necessarily
associated with HIV infection.
The pathogenesis of plasmablastic lymphoma
remains to be elucidated: Delecluse et al. found bcl-
2 protein overexpression only in a fraction of their
cases, and no evidence of bcl-2 gene rearrangement;
since all the cases also lacked bcl-6 expression, they
concluded that plasmablastic lymphoma probably
does not arise from the follicular center cells.5 In
keeping with these data, even the present case did
not show evidence of bcl-2 and bcl-6 genes
rearrangement.
Clinical features of intestinal lymphomas have
been recently reported in this journal.9 The possibil-
ity that plasmablastic lymphoma may develop in
the stomach should be kept in mind in order to
avoid misdiagnosis, especially on small bioptic
specimens: as a matter of fact, the absence of
leukocyte-common and B- and T-cell associated
antigens, as well as the expression of cytokeratin
and EMA might suggest the diagnosis of poorly dif-
ferentiated carcinoma. For this reason, it is worth
noting that parietal cell carcinoma of the stomach
(which expresses cytokeratin and lacks LCA) shows
a lymphoma-like histologic appearance.10 These
data suggest the usefulness of antibodies which rec-
ognize plasma cell-associated antigens, as well as
light and heavy immunoglobulin chains, which are
almost invariably expressed by plasmablastic lym-
phoma.4-6
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